Theriva Biologics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

시어리바 바이오로직스NYSEAMERICAN:TOVX · NYSE Amex · Healthcare · sector #17

$0.2340+5.41%

2026-10-07 close · prelim

Theriva Biologics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$26M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy